Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | AZN | AMGN | GILD | VRTX |
| Company | Arrowhead Pharma | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 68.47 | 92.32 | 330.72 | 125.71 | 459.39 |
| High | 71.30 | 92.61 | 334.38 | 126.25 | 464.44 |
| Low | 68.00 | 92.01 | 330.72 | 125.12 | 459.08 |
| Latest | 70.11 | 92.45 | 333.96 | 125.67 | 462.99 |
| Change | +0.28 | +0.31 | +2.47 | +0.48 | +3.78 |
| % Change | +0.40% | +0.34% | +0.75% | +0.38% | +0.82% |
| Volume | 677,900 | 1,184,600 | 833,600 | 1,606,300 | 310,200 |
| 20-Day Average Volume | 3,212,515 | 5,539,830 | 3,110,320 | 7,133,795 | 1,413,970 |
| Previous Close | 69.83 | 92.14 | 331.49 | 125.19 | 459.21 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 65.22 | 91.07 | 329.68 | 122.83 | 448.42 |
| 20-Day Raw Stochastic | 91.75% | 66.95% | 63.47% | 75.08% | 96.46% |
| 20-Day Relative Strength | 69.92 | 60.28 | 57.39 | 56.47 | 61.93 |
| Weighted Alpha | +310.74 | +42.71 | +27.94 | +32.44 | +14.19 |
| Today's Opinion | 100% Buy | 100% Buy | 96% Buy | 96% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 88% Buy | 96% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.19% since 12/17/25 | +2.88% since 12/17/25 | +2.44% since 12/17/25 | +3.55% since 12/17/25 | +3.00% since 12/17/25 |
| Low | 64.22 on 12/18/25 | 90.19 on 12/18/25 | 321.91 on 12/18/25 | 120.93 on 12/18/25 | 445.41 on 12/18/25 |
| High | 71.30 on 12/24/25 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | +58.40% since 11/24/25 | +1.02% since 11/24/25 | -0.10% since 11/24/25 | +0.32% since 11/24/25 | +9.20% since 11/24/25 |
| Low | 43.72 on 11/25/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 72.36 on 12/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.16 on 11/26/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | +113.55% since 09/24/25 | +22.68% since 09/24/25 | +19.60% since 09/24/25 | +10.56% since 09/24/25 | +22.93% since 09/24/25 |
| Low | 31.45 on 09/26/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 377.02 on 09/25/25 |
| High | 72.36 on 12/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | +339.29% since 06/24/25 | +31.06% since 06/24/25 | +20.35% since 06/24/25 | +17.23% since 06/24/25 | +2.82% since 06/24/25 |
| Low | 14.30 on 07/22/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 72.36 on 12/11/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,526,548 | 286,729,216 | 179,831,120 | 155,916,256 | 117,469,352 |
| Shares Outstanding, K | 135,880 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 829,450,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -1,630,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 256,470,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -23,750,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.28 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/25/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 02/09/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.16 | 15.16 | 15.29 | 29.99 |